Article Text
Statistics from Altmetric.com
Q In patients with chronic stable asthma, is bronchodilator and symptomatic response to high dose oral corticosteroids affected by smoking status?
Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ IM/Ambulatory care ★★★★★☆☆ Respirology ★★★★★★☆
METHODS
Design:
randomised, placebo controlled, crossover study.
Allocation:
concealed.*
Blinding:
blinded {patients, clinicians, data collectors, outcome assessors, and data analysts}†.*
Follow up period:
2 weeks.
Setting:
hospital clinics in Glasgow, UK
Patients:
59 patients who were 18–55 years of age (mean age 42 y, 72% men; based on 50 patients), had chronic asthma, forced expiratory volume in 1 second (FEV1) of 50–85% predicted, and ⩾15% reversibility of FEV1 after nebulised albuterol (2.5 mg). Exclusion criteria: asthma exacerbation, use of oral …